E-cigarette company Juul is now doing health research, but its first study could bring more questions than answers

Sarah Johnson/Flickr

  • On Saturday, for the first time in its roughly two-year history, e-cigarette company Juul presented some data from a clinical trial of its devices.
  • The company has a reputation for aggressively marketing its dessert-flavored nicotine products to teens, some of whom, research suggests, may now be at a higher risk of using regular cigarettes.
  • But Juul, which is now partially owned by Marlboro maker Altria, is now conducting scientific research.
  • In general, that research is considered a key step toward ensuring that a new product is not causing undo harm to people.
  • But the study still leaves many unanswered questions about the overall health of vaping, and also leaves unaddressed the issue of use by teens.

Juul, a Silicon Valley e-cigarette startup with a reputation for aggressively marketing its dessert-flavored nicotine products to teens, is now doing health research.

On Saturday the company, which is now partially owned by Marlboro maker Altria, presented a poster summary of a clinical trial comparing people who exclusively used its devices against people who smoked traditional cigarettes at an annual meeting for the Society for Research on Nicotine and Tobacco.

See the rest of the story at Business Insider

NOW WATCH: What happens to your body if you stop exercising

See Also:

SEE ALSO: See how Juul turned teens into influencers and threw buzzy parties to fuel its rise as Silicon Valley’s favorite e-cig company

DON’T MISS: The FDA just called out e-cig startup Juul and tobacco giant Altria for backing away from a pledge to fight teen vaping


Author: admin

Добавить комментарий

Этот сайт использует Akismet для борьбы со спамом. Узнайте как обрабатываются ваши данные комментариев.